RYAN BUSCH: Open Payments
NPI 1831590504 · PLEASANT GROVE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$186 in 12 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $316 · 2025 $186
Food & beverage: $186
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Viatris Specialty LLC | 1 | $20 |
| ABBVIE INC. | 1 | $17 |
| Cranial Technologies, Inc | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 2 | $15 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: Kerendia, YUPELRI, Ozempic, VRAYLAR, Doc Band, GARDASIL 9, ZENPEP, VOQUEZNA.
Industry payments across UT — which companies pay providers there.
